Peng Liu, Zhiming Li, Hong Cen, Zhengming Jin, Ai-min Zang, Xiuhua Sun, Sujun Gao, Junning Cao, Qingyuan Zhang, Yufu Li, Xun Lai, JiShi Wang, Fei Li, Shune Yang, Wenbin Qian, Hongli Wang, Xiaoyi Tang, Luyin Ding, Hui Zhou, Yuankai Shi. "Sintilimab (anti-PD-1) plus ifosfamide, carboplatin, and etoposide (ICE) in second-line classical Hodgkin lymphoma (cHL): Results of a multicenter, randomized, controlled, double-blind phase 3 study (ORIENT-21).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7007